Sastasundar Ventures Limited — PPTs, 06-02-2026: Investor Presentation

Sastasundar Ventures, soon to be Health X Platform, reported a strong turnaround in Q3 FY26, with revenue hitting 341.3 Cr, up 22% YoY. The company returned to profitability, posting a 0.4 Cr profit (vs. a 40 Cr loss last year). For the first nine months of FY26, profit reached 11.5 Cr, reversing a significant previous loss, with Gross Profit improving to 7.6%.

Growth is powered by its digital pharmacy, wellness, and diagnostics platform, primarily driven by Retailer Shakti (B2B) alongside a growing SastaSundar (B2C) segment. A key recent development is the company's regaining full operational control post its Flipkart Health+ partnership, positioning it ideally for future scaling.

Strategic priorities include expanding customer wallet share, acquiring new customers, and geographical penetration with planned fulfillment centers in Udaipur and Lucknow. AI integration across the value chain, category expansion into wellness and beauty, and scaling Genu Diagnostic services are key drivers. The company targets 30%+ CAGR, focusing on margin expansion and cost optimization.